AbbVie Delivers Strong Q1 Earnings Beyond Humira. This Dividend King Still Shines.

AbbVie (ABBV) has built a solid reputation among passive income-focused investors, backed by an impressive 54-year streak of ...
U.S. News & World Report

AbbVie Sees No Outsized Tariff Exposure, Boosts Profit Forecast

(Reuters) -AbbVie said on Thursday its tariff exposure is not expected to exceed that of rivals, and raised its 2025 profit forecast citing strong sales of its newer immunology drugs Skyrizi and ...
Yahoo

Drugmaker AbbVie expects Humira volume erosion to worsen

(Reuters) -AbbVie expects a drop in sales volumes of its blockbuster arthritis drug Humira to deepen after recent changes by U.S. pharmacy benefit managers and as patients shift to other drugs. Its ...
NBC DFW

Healthy Returns: Sales of Humira are plunging, but AbbVie has two promising successors

Think a friend or colleague should be getting this newsletter? Share this link with them to sign up. Good morning! Sales of AbbVie's Humira are plummeting as the once-top-selling drug fights ...